Biomaterial
Zybio has started to involve in biomaterials production due to its dramatic nation-wide expansion in the recent
years. An independentbiomaterial R&D center was founded to the production of a variety of biomaterials such
as antigens and antibody to guarantee as well as controlling the quality of our lineup products.
Our antigens (native or recombinant) and antibodies (monoclonal or polyclonal) are validated for application in
most technologies which are currently applied for in-vitro diagnosis clinical diagnostics assays.
most technologies which are currently applied for in-vitro diagnosis clinical diagnostics assays.
Antisera
| Antisera | Source | Application | ||||
|---|---|---|---|---|---|---|
| ApoA1 | Goat | TIA | ||||
| ApoB | Goat | TIA | ||||
| PA | Goat | TIA | ||||
| lgA | Goat | TIA | ||||
| lgG | Goat | TIA | ||||
| lgM | Goat | TIA | ||||
| c3 | Goat | TIA | ||||
| C4 | Goat | TIA | ||||
| ApoE | Goat | TIA | ||||
| FIB | Goat | TIA | ||||
| CER | Goat | TIA | ||||
| C1Q | Goat | TIA | ||||
| ALB | Goat | TIA |
Antigen
| Antigen | Purity | Source | Application | |||||
|---|---|---|---|---|---|---|---|---|
| NT-proBNP | ≥95% | E.coli,Recombination | POCT,PETIA,CLIA | |||||
| H-FABP | ≥95% | E.coli,Recombination | POCT,PETIA,CLIA | |||||
| PCT | ≥95% | E.coli,Recombination | POCT,PETIA,CLIA | |||||
| 32-MG | ≥95% | E.coli,Recombination | POCT,PETIA,CLIA | |||||
| CysC | ≥95% | E.coli,Recombination | POCT,PETIA,CLIA | |||||
| a1-MG | ≥95% | E.coli,Recombination | POCT,PETIA,CLIA | |||||
| RBP4 | ≥95% | E.coli,Recombination | POCT,PETIA,CLIA | |||||
| MYO | ≥95% | E.coli,Recombination | POCT,PETIA,CLIA | |||||
| PGl | ≥95% | E.coli,Recombination | POCT,PETIA,CLIA | |||||
| PGl | ≥95% | E.coli,Recombination | POCT,PETIA,CLIA | |||||
| IGFBP-1 | ≥95% | E.coli,Recombination | POCT,PETIA,CLIA | |||||
| BNP | ≥95% | Recombination | POCT,PETIA,CLIA | |||||
| C-peptide | ≥95% | Recombination | POCT,PETIA,CLIA | |||||
| Lp-PLA2 | ≥95% | E.coli,Recombination | POCT,PETIA,CLIA | |||||
| CRP | ≥95% | E.coli,Recombination | POCT,PETIA,CLIA | |||||
| D-Dimer | ≥95% | Recombination | POCT,PETIA,CLIA | |||||
| NGAL | ≥95% | Recombination | POCT,PETIA,CLIA | |||||
| SAA | ≥95% | Recombination | POCT,PETIA,CLIA | |||||
| cTnl | ≥95% | Recombination | POCT,PETIA,CLIA | |||||
| ALB | ≥95% | Native | POCT,PETIA,CLIA |
Monoclonal Antibody
| Monoclonal Antibody | Purity | Source | Application | |||||
|---|---|---|---|---|---|---|---|---|
| NT-proBNP | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| PCT | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| NGAL | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| Micro-Alb | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| CysC | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| BNP | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| D-D | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| Pres1 | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| cTnl | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| MYO | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| CK-MB | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| IGFBP-1 | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| FFN | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| H-FABP | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| CRP | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| SAA | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| HbA1c | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| Lp-PLA2 | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| PGI | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| PGII | ≥95% | Mouse | POCT,PETIA,CLIA |
Polyclonal Antibody
| Polyclonal Antibody | Purity | Source | Application | |||||
|---|---|---|---|---|---|---|---|---|
| CysC | ≥95% | Rabbit | PETIA | |||||
| 32-MG | ≥95% | Rabbit | PETIA | |||||
| a1-MG | ≥95% | Rabbit | PETIA | |||||
| MYO | ≥95% | Goat | PETIA | |||||
| NT-proBNP | ≥95% | Goat | POCT,PETIA | |||||
| CRP | ≥95% | Rabbit | PETIA | |||||
| RBP | ≥95% | Goat | PETIA | |||||
| SAA | ≥95% | Rabbit | PETIA | |||||
| Fer | ≥95% | Goat | PETIA | |||||
| Trans-Fer | ≥95% | Goat | PETIA | |||||
| FDP | ≥95% | Goat | PETIA | |||||
| RBC | ≥95% | Rabbit | POCT | |||||
| NGAL | ≥95% | Goat | PETIA |